Literature DB >> 8495621

Lack of regional variation in IDDM risk in Japan. Japan IDDM Epidemiology Study Group.

.   

Abstract

OBJECTIVE: To examine the intracountry variation of IDDM incidence in Japan and compare it with data from the British Isles and the U.S. RESEARCH DESIGN AND METHODS: IDDM incidence was determined with a standardized registry approach in five geographically different areas in Japan (Hokkaido, Tokyo, Yokohama, Osaka, and Kagoshima) with a total at-risk population < 15 yr of age of 4.4 million. Data collection was completed under the guidelines of the World Health Organization DiaMond project.
RESULTS: The incidence and patterns of disease were remarkably similar across the five environmentally different areas. Incidence rates per 100,000 were very low and almost identical from northern to southern Japan (Hokkaido, 2.07; Tokyo, 1.65; Yokohama, 1.66; Osaka, 1.78; and Kagoshima, 1.93). This remarkably low intra-country variation of 0.4/100,000 stands in sharp contrast with the 13.0/100,000 regional variation in the British Isles and the 10.6/100,000 variation in the U.S.
CONCLUSIONS: The results suggest that the remarkable genetic homogeneity in Japan may produce uniformity of incidence.

Entities:  

Mesh:

Year:  1993        PMID: 8495621     DOI: 10.2337/diacare.16.5.796

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  3 in total

1.  Age-dependent association of HLA-A24 in Japanese IDDM patients.

Authors:  M Mizota; Y Uchigata; S Moriyama; K Tokunaga; N Matsuura; J Miura; T Juji; Y Omori
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

Review 2.  Type 1 diabetes in Japan.

Authors:  E Kawasaki; N Matsuura; K Eguchi
Journal:  Diabetologia       Date:  2006-03-28       Impact factor: 10.122

3.  Current smoking status may be associated with overt albuminuria in female patients with type 1 diabetes mellitus: a cross-sectional study.

Authors:  Kenta Okada; Jun-Ichi Osuga; Kazuhiko Kotani; Hiroaki Yagyu; Michiaki Miyamoto; Shoichiro Nagasaka; Shun Ishibashi
Journal:  Tob Induc Dis       Date:  2012-08-10       Impact factor: 2.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.